Results 61 to 70 of about 1,895,251 (293)

Operational Transresistance Amplifier Based PID Controller

open access: yesAdvances in Electrical and Electronic Engineering, 2015
This paper presents Operational transresistance amplifier (OTRA) based proportional-integral- derivative (PID) controller with independent electronic tuning of proportional, integral, and derivative constants.
Rajeshwari Pandey   +3 more
doaj   +1 more source

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment [PDF]

open access: yesJournal of Neuro-Oncology, 2016
1 Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 2 Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 3 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 4 Department of Pathology, The Johns Hopkins ...
Dimitrios, Mathios   +10 more
openaire   +2 more sources

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

DataSheet_1_A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.docx

open access: yes, 2023
BackgroundHarnessing the anti-tumor immune system response by targeting the program cell death protein (PD-1) and program cell death ligand protein (PD-L1) axis has been a major breakthrough in non-small cell lung cancer (NSCLC) therapy.
Alfonso Calvo (487616)   +14 more
core   +1 more source

A pragmatic macroeconomic default risk adjustment in developing countries

open access: yesSouth African Journal of Economic and Management Sciences
Background: The expected credit loss (ECL) framework of International Financial Reporting Standards Foundation (IFRS) 9 typically comprises three components: probability of default (PD), loss given default (LGD) and exposure at default (EAD). Among these,
Suben Moodley   +2 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Light-Activated Azobenzene Peptide Inhibitor of the PD-1/PD-L1 Interaction [PDF]

open access: yes
Inhibiting the protein-protein interaction between programmed cell death 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1) has become a focal point in immunotherapy for cancer treatments.
Deanne, Hayward   +4 more
core   +2 more sources

Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.

open access: yes, 2021
Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.
Chien-Hsin Ho (2211316)   +20 more
core   +1 more source

Differential Diagnosis Of Multiple-System Atrophy With Parkinson’s Disease By External Anal- And Urethral-Sphincter Electromyography

open access: yesNeuropsychiatric Disease and Treatment, 2019
Feng Qiu,1,* Kunyu Wang,1,* Tingting Li,2 Dandan Song,3 Zhiwei Wang,1 Hailing Zhang,4 Jianguo Liu,1 Ming Ren,5 Xiaokun Qi1 1Department of Neurology, Sixth Medical Center of Chinese PLA General Hospital, Beijing, 100048, People’s Republic of China ...
Qiu F   +8 more
doaj  

HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis

open access: yesOpen Medicine, 2021
Parkinson’s disease (PD) is a prevalent neurodegenerative disease. Currently, the molecular mechanisms underlying the progressions of PD are not fully understood. The human neuroblastoma cell line SH-SY5Y has been widely used as an in vitro model for PD.
Wei Bo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy